Introduction
tega and Osborne, 1989; De Leon et al., 1992) , or dominant negative mutants (Prager et al., 1994; D'Ambrosio et al., 1996; et al., 2002b) . This hypothesis was further reinforced by the growth of IGF-IR-driven fibrosarcomas.
Ser/Thr: serine/threonine-specific protein kinase.
Results
Small molecules belonging to the pyrrolo [2,3-d] pyrimidine class the recombinant kinase domains used in the in vitro kinase were identified in a high-throughput screening of our in-house assay. Thus, at the cellular level, NVP-AEW541 is highly seleccompound archive as inhibitors of the IGF-IR in vitro kinase tive against the IGF-IR, as compared to both the InsR and other activity. This compound class was subjected to a medicinal tyrosine kinases. chemistry program aimed at optimizing the potency and selecGiven the survival function that has been ascribed to IGF-IRtivity toward the IGF-IR kinase, as well as their drug-like propermediated signaling and the requirement of IGF-IR mediated ties. NVP-AEW541 is a representative example of such an optisignaling for cellular transformation, the ability of the compound mization process, whose potency and selectivity was first to inhibit IGF-I-mediated survival of MCF-7 cells in the absence assessed in a series of in vitro kinase assays using different of serum and to prevent their ability to grow in an anchoragerecombinant kinase domains or purified kinases and synthetic independent manner was analyzed. NVP-AEW541 was shown peptide substrates (Table 1) . The compound was found to inhibit to inhibit IGF-I-mediated survival of MCF-7 cells (Table 3) , as the in vitro kinase activity of the recombinant IGF-IR kinase well as their ability to grow in soft agar (Table 3) , at concentradomain with an IC 50 value of 0.15 M and to be equipotent tions consistent with its capacity to inhibit receptor autophosagainst the recombinant InsR kinase domain. NVP-AEW541 disphorylation (data not shown). played at least 10-fold selectivity toward the IGF-IR, as comAs an effective therapeutic agent, NVP-AEW541 must also pared to most of the other kinases tested. The only exceptions be able to inhibit IGF-I-stimulated signaling ( Figure 1 ) and prolifwere represented by the Flt-1, Flt-3, and Tek kinases, where the eration in the presence of serum (Table 3 ). The cell line selected compound inhibited the respective recombinant kinase domains for these tests, NWT-21, is a NIH3T3 derivative that stably exwith IC 50 values 3-to 4-fold higher than those measured for the IGF-IR.
In order to assess the ability of NVP-AEW541 to inhibit its target in cells, and to test the selectivity of the compound against there are conformational differences between the native forms independent determinations is indicated with n.
of these receptor tyrosine kinases that are not recapitulated by The ability of NVP-AEW541 to inhibit IGF-I-mediated survival was assessed in MCF-7 cells in the absence of serum. Inhibition of anchorage-independent growth by NVP-AEW541 was assessed in a soft agar assay using MCF-7 cells. The proliferative capacity of NWT-21 cells (NIH3T3 stably expressing the human IGF-IR) growing in serum-containing media was determined in the absence and presence of increasing concentrations of the compound. The IC 50 values are expressed as mean Ϯ SEM and the number of independent determinations is indicated with n.
presses the human IGF-IR. IGF-IR overexpression in murine fibroblasts is reported to result in transformation, as assayed by focus formation and tumor growth in nude mice, indicating that the NWT-21 cells would also represent a suitable IGF-IR-driven model for further in vivo efficacy studies. IGF-IR-medi- phospho-MAPK and phospho-GSK-3␤ were observed in independent experiments, where NWT-21 cells were exposed in vitro to NVP-AEW541 (data not shown). gated upon oral administration of NVP-AEW541. Having demonTo assess and compare the activity of IGF-IR inhibitors in strated the ability of the compound to abrogate IGF-I signaling vivo, a pharmacodynamic model was established. Murine lung in vivo, its effect on subcutaneously implanted NWT-21 tumors was selected as a suitable tissue based on the observation that was assessed. In line with the observations obtained in lung it contains detectable levels of the receptor and that stimulation tissue, oral administration of NVP-AEW541 resulted in abrogawith IGF-I leads to receptor autophosphorylation and activation tion of basal and IGF-I-induced receptor, and PKB and MAPK of downstream signaling intermediates, including PKB and phosphorylation in the NWT-21 tumor xenograft (Figure 3 ). MAPK. As shown in Figure 2 , ligand-mediated IGF-IR autophosFinally, the in vivo antitumor activity of NVP-AEW541 was phorylation and phosphorylation of PKB and MAPK were abroassessed in the NWT-21 fibrosarcoma tumor model (Figure 4 the cellular level (27-fold), but not in the in vitro kinase assays, ing with the notion that IGF-IR-mediated signaling is key for the growth of tumor cells under anchorage-independent conditions, but less so for their growth as adherent monolayer, higher concentrations of compound were generally required to inhibit proliferation of tumor cells in monolayer cultures than in the soft agar. Furthermore, cell-cell contact has been observed to negatively influence the sensitivity of cells to IGF-IR inhibitors (data not shown), probably because other, cell-contact-driven, survival mechanisms come into play. Thus, inhibition of IGF-IR signaling is likely to be more efficacious in inhibiting the onset of metastasis than the growth of an established primary tumor, unless the latter is exquisitely IGF-dependent. This view is supported by studies in which impairment of IGF-IR function, either through the use of antisense molecules or dominant negative mutants (Long et al., 1995; Dunn et al., 1998) , led to a reduction in the number of metastasis, but not the primary tumor. inhibit IGF-IR-mediated signaling in both a pharmacodynamic model and in subcutaneously implanted NWT-21 tumors. Consistently with IGF-IR signaling inhibition, NVP-AEW541 was found to significantly impair the growth of subcutaneously imwhere recombinant protein fragments corresponding to the replanted NWT-21 tumors, thereby demonstrating the efficacy of spective kinase domains are used. It is conceivable that structhis inhibitor toward IGF-IR driven tumors in vivo. tural features peculiar to each of these two receptors, but absent Despite the cellular selectivity achieved toward the IGF-IR, in the recombinant kinases, affect and differentiate the conforas compared to the InsR, there remains a potential risk of such mation of the respective kinase domains in the context of the a compound interfering with glucose/insulin metabolism. In fact, native receptors. Similar observations were obtained in the case the two receptors can form heterodimers, a situation where a of Flt-3, where the selectivity of NVP-AEW541 toward the IGF-IR selective IGF-IR inhibitor would prevent crossphosphorylation improved from 2.8-fold in vitro to 21-fold at the cellular level and activation of the associated InsR heterodimeric partner. (data not shown).
Alternatively, the compound could in principle accumulate at The compound was found to fulfill the key characteristics concentrations high enough to also inhibit the InsR. To assess expected from an IGF-IR inhibitor. It effectively inhibits the surthis potential risk, plasma glucose and plasma insulin were monvival function ascribed to IGF signaling and prevents the ability itored in mice treated with efficacious doses (50 mg/kg, bid, of transformed cells to grow in an anchorage-independent manp.o.) of NVP-AEW541. No significant differences were observed ner, both events occurring at concentrations that are consistent with its capacity to inhibit IGF-IR autophosphorylation. In keepwhen the plasma glucose and insulin levels of vehicle and com- Thus, NVP-AEW541 specifically targets the IGF-IR and repat Ϫ80ЊC. The oocytes were then homogenized following thawing and centrifuged as described (Arion et al., 1988; Rialet and Meijer, 1991 The catalytic domain of PKA was assayed according to the manufacturer's pFbacGST2T, and pFbacGSTx3 Bac-to-Bac donor vectors were generated procedure (Sigma; St. Louis, Mo., USA). In brief, liophilized PKA from rabbit from the pFastBac1 vector (GIBCO-BRL; Cheshire, UK) by insertion of the muscle was reconstituted in nanopure water and frozen Ϫ20ЊC as stock GST coding sequence from pAcG1, pAcG2T, and pAcG3X, respectively aliquots (5000 U/ml). The heptapeptide Leu-Arg-Arg-Ala-Ser-Leu-Gly, (PharMingen; San Diego CA, USA). The kinase coding sequences were then known as Kemptide (Bachem; Bubendorf, Switzerland), was used as peptide fused to GST and sequence identity was confirmed.
substrate. The enzyme assay was carried out for 20 min at RT in a final Viruses for each of the kinases were generated in Sf9 (ATCC# CRLvolume of 30 l containing 1 U of PKA, 100 mM MES-NaOH (pH 7.0), 15 1711) , 1992) . Active Ras (v-Ras) is required to recruit c-Raf-1 to the cell 2 mM EDTA, 1% NP-40, 1 mM DTT, 1 mM PMSF). The cells were stirred membrane, and v-Src is required to phosphorylate c-Raf-1 to fully activate on ice for 15 min and then centrifuged at 5000 rpm for 20 min. The clear it (Williams et al., 1992) . IB, expressed in bacteria as a His-tagged protein, lysate was loaded onto a 2 ml glutathione-sepharose column (Pharmacia; was used as substrate for the c-Raf-1 kinase. Bacteria were lysed by sonica-Dü bendorf, Switzerland) and washed three times with 10 ml of 25 mM tion (microtip limit setting for 3 times at 1 min each) in sonication buffer (50 Tris•HCl (pH 7.5), 2 mM EDTA, 1 mM DTT, and 200 mM NaCl. The GSTmM Tris·HCl [pH 8.0], 1 mM DTT, 1 mM EDTA) and centrifuged at 10,000 ϫ tagged proteins were then eluted by 10 applications (1 ml each) of 25 mM g for 15 min. The supernatant was mixed with ammonium sulfate to give a Tris·HCl (pH 7.5), 10 mM reduced glutathione, 100 mM NaCl, 1 mM DTT, final concentration of 30%. This mixture was rocked for 15 min at 4ЊC then and 10% Glycerol, and stored at Ϫ70 Њ C.
spun at 10,000 g for 15 min. The pellet was resuspended in binding buffer The activities of protein kinases were assayed in the presence or abcontaining 10 mM BSA. This solution was applied to Ni-agarose and washed sence of inhibitors by measuring the incorporation of 33 P from [␥ 33 P]ATP according to the manufacturer. IB was eluted from the column using elution (1000 Ci/mmol; Amersham; Little Chalfont, UK) into appropriate substrates.
buffer ( The HER-1 and HER-2 cDNAs were kindly provided by Dr. Nancy Hynes compound in duplicate, at four concentrations (usually 0.01, 0.1, 1, and 10 (FMI, Basel, Switzerland). Recombinant baculovirus was generated that ex-M). One unit of protein kinase activity is defined as 1 nmole of 33 P transferred presses the amino acid region 668-1210 and 676-1255 of the cytoplasmic from [␥ 33 P]ATP to the substrate protein per minute per mg of protein at 37ЊC. kinase domains of human HER-1 and HER-2, respectively. The coding se-PKC-␣ quence for HER-4 kinase domain (aa 676-1308) was amplified by PCR from Expression of recombinant bovine PKC-␣ using the baculovirus system has a human uterus cDNA library. The kinase assays with purified GST-HER-1 been described (Stabel et al., 1991; Geiges et al., 1997) . PKC-␣ was partially (3 ng), GST-HER-2 (10 ng), and GST-HER-4 (4 ng) were carried out for 15 purified by DEAE sepharose (Pharmacia; Dü bendorf, Switzerland). The enmin at RT in a final volume of 30 l containing 20 mM Tris·HCl (pH 7.5), 10 zyme assay was carried out for 20 min at RT in a final volume of 30 l containing 0.1-0.3 U of PKC-␣, 20 mM Tris•HCl (pH 7.4), 10 mM Mg(NO 3 ) 2 ϫ mM MgCl 2 , 3 mM MnCl 2 , 0.01 mM Na 3 VO 4 , 1 % DMSO, 1 mM DTT, 3 g/mL poly(Glu,Tyr) 4:1 (Sigma; St. Louis, Mo., USA), and 2.0 M ATP (␥-[ 33 P]-ATP Ins-R cDNA (Pronk et al., 1994) . The cells were cultured in DMEM medium containing 10% FCS and 1% penicillin/streptomycine. The human epider-0.1 Ci). c-Abl moid carcinoma cell line A431 (ATCC CRL1555) was grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine The His-tagged kinase domain of c-Abl was cloned and expressed in the baculovirus/Sf9 system as described (Bhat et al., 1997) . A protein of 37 kDa serum, in presence of 1% sodium pyruvate and 1% penicillin/streptomycin. A31 cells (BALB/3T3 clone A31, ATCC CCL-163) were grown in DMEM high-(c-Abl kinase) was purified by a two-step procedure over a cobalt metal chelate column followed by an anion exchange column (Pharmacia; Dü benglucose with 10% FCS, 1% L-Glutamine, and 1% penicillin/streptomycin. GIST882 cells, originally derived from a human gastrointestinal stromal tudorf, Switzerland) with a yield of 1-2 mg/l of Sf9 cells (McGlynn et al., 1992) . Tyrosine protein kinase assays with purified c-Abl contained in a total volume mor, were obtained from Jonathan A. Fletcher (DFCI, Boston) and cultivated in RPMI 1640, supplemented with 15% FCS, and 2 mM glutamine. These of 30 l: 10 ng c-Abl kinase, 20 mM Tris·HCl (pH 7.5), 10 mM MgCl 2 , 10 M Na 3 VO 4 , 1 mM DTT, 1 % DMSO, 5 M ATP (0.07 Ci/assay [␥-
33 P]-ATP) cells express a mutated kit that is constitutively activated. The murine myeloid progenitor cell line 32Dcl3 transfected with the p210 Bcr-Abl expression and 30 g/ml Poly-AEKY (poly-Ala,Glu,Lys,Tyr-6:2:5:1; Sigma; St. Louis, Mo., USA) and were carried out for 10 min at RT. vector pGDp210Bcr/Abl (32D-bcr/abl) was obtained from J. Griffin (Bazzoni et al., 1996) . The cells express the fusion bcr-abl protein with a constitutively c-Src The baculovirus expressing full-length chicken c-Src was generated as a active abl kinase and proliferate in an IL-3-independent manner. The cells were grown in RPMI 1640, 10% fetal calf serum, 2 mM glutamine. All cell GST fusion protein. The assay contained in a final volume of 30 l: 5 ng c-Src kinase, 20 mM Tris·HCl (pH 7.5), 10 mM MgCl 2 , 0.01 mM Na 3 VO 4 , 1% culture reagents were purchased from Invitrogen (Basel, Switzerland). DMSO, 1 mM DTT, 25 g/ml poly(Glu,Tyr (c-Kit, Bcr-Abl). For all described capture ELISAs, phoshorylated target was of the cytoplasmic kinase domain of the human insulin receptor, Ins-R, was detected using the AP-labeled anti-phosphotyrosine Ab PY20(AP) as second generated. Tyrosine protein kinase assays with purified GST-IGF-IR (100 ng with 3% BSA in PBST (PBS containing 0.05% Tween20). 40 l of each cell Flt-3 lysate was transferred to the precoated plates, mixed with 40 l of an alkaline Recombinant baculovirus that expresses the amino acid region 563-993 of phosphatase (AP) labeled anti-phosphotyrosine Ab (PY20[AP], Zymed; Bathe cytoplasmic kinase domains of human Flt-3 was generated. The coding sel, Switzerland), diluted to 0.2 g/ml in RIPA buffer, and incubated overnight sequences for the cytoplasmic domain of Flt-3 were amplified by PCR from at 4ЊC. After washing (PBST) and incubation for 45 min at RT with the human c-DNA libraries (Clontech; Palo Alto CA, USA). Tyrosine protein kinase luminescent AP-substrate CDPStar RTU with Emerald II (90 l/well), luminesassays with purified GST-Flt-3 was carried out for 15 min at RT in a final cence was measured using a Packard Top Count Scintillation Counter. volume of 30 l containing 200-1800 ng of enzyme protein (depending on InsR the specific activity), 20 mM Tris•HCl (pH 7.6), 3 mM MnCl 2 , 3 mM MgCl 2 , A commercial monoclonal anti-Ins-R-␤-subunit antibody (Neomarkers Ab6, 1 mM DTT, 10 M Na 3 VO 4 , 3 g/mL poly(Glu,Tyr) 4:1 (Sigma; St. Louis, Basel, Switzerland) was used as a capture antibody for the insulin receptor.
Black ELISA plates were coated overnight with 50 l 0.75 g/ml Ab6 in PBS Flt-4 at 4ЊC, washed with PBST and blocked with PBST containing 3% BSA. A fusion protein of GST and the cytoplasmic domain of human Flt-4 (GST-5 ϫ 10 3 A14 cells/well were plated on 96-well plates (Costar; Wohlen, Flt-4) expressing the amino acid regions 725-1298 was provided by Dr.
Switzerland) in complete growth medium and incubated at 37ЊC, 5% CO 2 Marmé (Klinik fü r Tumour Biologie, Freiburg, Germany). GST-Flt-4 was asuntil they reached confluency. After starvation for 24 hr in DMEM without sayed for 15 min at RT in a final volume of 30 l containing 200-1800 ng FCS, followed by incubation for 90 min in the absence or presence of test of enzyme protein (depending on the specific activity), 20 mM Tris•HCl (pH compound, the cells were stimulated with 5 g/ml insulin for 10 min at 37ЊC. 7.6), 3 mM MnCl 2 , 3 mM MgCl 2 , 1 mM DTT, 10 M Na 3 VO 4 , 3 g/ml poly(Glu, Immediately after stimulation, the cells were washed twice with cold PBS, Tyr) 4:1 (Sigma; St. Louis, MO, USA), 1% DMSO, 8.0 M ATP (␥-[ 33 P]-ATP and lysed at 4ЊC with 150 l/well freshly prepared RIPA buffer. 50 l of each 0.1 Ci).
cell lysate was transferred directly from the cell culture plate to the precoated plate and incubated overnight at 4ЊC. Following washing with PBST, the plates were incubated for 2 hr at RT with 50 l/well PY20(AP), diluted 1:10000 Cell lines NWT-21 cells are NIH3T3 mouse fibroblasts that stably overexpress the in RIPA buffer (final concentration: 0.1 g/ml). The final washing with PBST was followed by addition of 90 l/well chemiluminescent AP-substrate human IGF-IR and were generated as previously described (Kato et al., 1993) by Dr. Thomas Geiger (Novartis Pharma AG). The cells were passaged (CDPStar RTU with Emerald II) and incubation for 45 min at RT (dark). Luminescence was measured (as counts per second, CPS) with a Packard in DMEM high glucose, 10% FBS, and 1% Na-Pyruvate. A14 cells are NIH3T3 mouse fibroblast cells that have been stably transfected with human TopCount Microplate Scintillation Counter.
HER-1
Cruz; Nunningen, Switzerland) overnight at 4ЊC on a rotating wheel. 30 l Protein G Sepharose (Sigma; St. Louis, Mo., USA) were then added and A431 cells grown close to confluency in 96 well tissue culture plates were starved for 24 hr in medium with 0.5% FBS, followed by incubation with incubation continued for 2 hr at 4ЊC. The Protein G Sepharose was collected, washed three times with lysis buffer, and resuspended in SDS-gel sample serial dilutions of the compound for 90 min. After stimulation with a final concentration of 50 ng/ml EGF (Upstate Biotechnology; 01-102, Frankfurt, buffer. Samples were loaded on 7.5% SDS gels (PAGErR Gold precast gels, Bioconcept; Allschwil, Switzerland) and Western Blot was performed using Germany) for 10 min, cells were washed and lysed in 150 l lysis buffer. For the ELISA, 50 ng/well anti-EGFR Ab5 from NeoMarkers (MS-316-P;
anti-phospho-Tyrosine antibody (4G10) followed by a secondary HRP-linked anti-mouse Ig antibody (NA931V, Pharmacia, Dü bendorf, Switzerland). MemBasel, Switzerland) was coated to black ELISA plates. PDGFR branes were reprobed with anti-IGF-IR␤ antibody (sc-713; Santa Cruz; Nunningen, Switzerland). Alternatively, IGF-IR tyrosine phosphorylation was de-A31 cells grown in 96-well tissue culture plates close to confluency were starved for 4 hr in the presence of 0.5% FCS, followed by incubation with termined on 50 g of total cell lysates obtained from NWT-21 cells cultured in vitro using an anti-phospho-IGF-IR antibody (407707; Calbiochem/Merck; compound in starving medium for 2 hr. Subsequently, the cells were stimulated with recombinant human PDGF BB (BACHEM, Bubendorf, Switzerland) Darmstadt, Germany), followed by a secondary HRP-coupled anti rabbit IgG antibody (NA934V; Pharmacia; Dü bendorf, Switzerland). at 50 ng/ml final concentration for 10 min followed by washing and lysis in 70 l/well lysis buffer. For the ELISA, 50 ng/well anti-PDGF-R Receptor Type PKB phosphorylation was determined using 20 g of the total cell extract, resolved on 12% SDS gels (PAGErR Gold precast gels, Bioconcept; A/B antibody from Upstate Biotechnology (06-495; Frankfurt, Germany) was coated to black ELISA plate.
Allschwil, Switzerland). Western blot was performed using an anti-Phospho-PKB (Ser473) antibody (9271, Cell Signaling; Frankfurt, Germany) or an antic-Kit 96-well tissue culture plates were treated with 1.5% gelatin solution in nano-PKB antibody (9272, Cell Signaling; Frankfurt, Germany), followed by a secondary HRP-linked anti-mouse Ig antibody (NA931V, Pharmacia; Dü benpure water for 30-60 min at 37ЊC prior to seeding the GIST882 cells to improve adherence and cell growth. The gelatin (EIA purity reagent; BIORAD, dorf, Switzerland). MAPK kinase phosphorylation was determined using an antibody speReinach, Switzerland) was sterilized before use by heating (autoclave). Cells were grown close to confluency in gelatin-precoated 96-well tissue culture cific for phosphorylated threonine 202/tyrosine 204 of p44/42 MAPK (4102, Cell Signaling; Frankfurt, Germany). The level of MAPK was monitored with plates. Incubation with compound for 90 min was followed by washing and cell lysis in 100 l/well cold lysis buffer. For the ELISA, 100 ng per well a specific antibody (4101, Cell Signaling; Frankfurt, Germany). Detection was performed using the ECL Plus western blotting detection monoclonal anti-CD117 antibody (Diaclone; Besanç on, France) was coated to black ELISA plates.
system (Amersham biosciences; Dü bendorf, Switzerland). Bcr-Abl 200,000 32D-Bcr-Abl cells were seeded per well in 96-well round bottom Proliferation assay tissue culture plates and treated with compound for 90 min followed by Between 3000 and 6000 cells/well were seeded in 96-well plates with a total washing and cell lysis in 150 l/well lysis buffer. For the ELISA, 50 ng/well media volume of 100 l/well. Increasing concentrations of the compound of the rabbit polyclonal anti-abl-SH3 domain (Ab 06-466; Upstate; Frankfurt, were added 24 hr thereafter in quadruplicate. 72 hr later, cells were fixed Germany) was coated to black ELISA plates.
by addition of 25 l/well Glutaraldehyde (20%) and incubation for 10 min at RT. Cells were then washed 2ϫ with 200 l/well H 2 O and 100 l Methylene Blue (0.05%) was added. After incubation for 10 min at RT, cells were IGF-I survival assay MCF-7 cells were plated in 96-well dishes at 3000 cells/well in MEM EBS, washed 3ϫ with 200 l/well H 2 O. 200 l/well HCl (3%) was added, and following incubation for 30 min at RT on a plate shaker, absorbance was 10% FCS, 1% Glutamate, 1% Na Pyruvate, and 10 g/ml bovine insulin (Invitrogen; Basel, Switzerland). 24 hr after plating, medium was removed measured at 650 nm. and the cells were washed twice with PBS. 100 l of serum-free medium containing IGF-1 (50 ng/ml) and 0.1% BSA was added in the presence of Ex vivo analysis increasing concentrations of compound. 72 hr after treatment started, celluStimulation with IGF-I was induced by i.v. injection of the growth factor (0.1 lar viability was assayed using the Cell Titer 96R Aqueous One Solution Cell mg/kg) 5 min prior to euthanasia. Organs and tumor specimens derived Proliferation Assay (Promega; Wallisellen, Switzerland). from treated animals were immediately snap frozen upon removal from the animal. Samples were pulverized in a liquid nitrogen-cooled mortar and an aliquot of approximately 50 mg placed in a dry-ice-cooled Eppendorf tube. Soft agar assay MCF-7 cells were grown, as described above, and the soft agar assay was A 10 times equivalent volume of boiling extraction buffer was added (100 mM Tris·HCl [pH 7.4], 2% SDS, 10 mM DTT, 2 mM Sodium Vanadate, 0.5 adapted to 24-well plates according to the method described previously (Freedman and Shin, 1974) . NVP-AEW541 was added directly to the agarmM EDTA, 0.1 mM PMSF). Following extensive vortexing, the sample was boiled for 10 min at 95ЊC with occasional vigorous vortexing. Following containing medium, to final concentrations of 30 to 300 nM. The basal layer contained 0.5 ml per well of 0.8% bacto agar (Invitrogen; Basel, Switzerland) preclearing by centrifugation at 4ЊC and 14,000 rpm for 15 min, the supernatant was transferred to a precooled Eppendorf and the protein concentration in MCF7 growth medium. The plates were covered and stored in an incubator (37ЊC, 5% CO 2 ) for at least 30 min to allow the medium to solidify before assayed. Immunoprecipitation and Western blot analysis were carried out as described above. addition of the top agar layer. 5000 MCF-7 cells per well were embedded in 0.5 ml top layer of 0.4% agar in growth medium. After 3 weeks incubation at 37ЊC, 5% CO 2 , cells were fixed, stained by crystal violet, positive colonies
In vivo efficacy study (diameter Ͼ 40 m) counted, and the transformation efficiency determined All experimental procedures strictly adhered to the Eidgenö ssisches using a Kontron KS-400 image analysis system (Zeiss; Jena, Germany).
Tierschutzgesetz and the Eidgenö ssische Tierschutzverordnung and were covered by the permit No. 1763 issued by the Kantonale Veterinä ramt BaselStadt (Switzerland). Female Harlan athymic nude mice were obtained from Western blot analysis of phospho-IGF-IR, phospho-PKB, and phospho-MAPK a Novartis internal breeding population (Hsd:Athymic Nude-nu) and were kept under optimal hygienic conditions. The initial body weight of the animals IGF-IR phosphorylation was tested in log phase cells. The compound (dissolved in DMSO) was added 20 min before stimulation with IGF-I (50 ng/ml) at time of arrival was between 18 and 25 g. The animals were kept in Makrolon type III cages (8 animals per cage) in a 12 hr/12 hr light/dark cycle, to reach final concentrations ranging from 0.1 to 10 M. Ten minutes thereafter, the dishes were placed on ice, cells rinsed with 10 ml cold PBS, and and food and water were ad libitum. At the end of the experiment, animals were sacrificed by CO 2 inhalation. collected in 500 l lysis buffer (50 mM Tris·HCl [pH 7.5], 120 mM NaCl, 20 mM NaF, 1 mM EDTA, 6 mM EGTA, 15 mM pNPP, 15 mM SodiumpyrophosGeneration of NWT-21 tumor fragments and treatment of animals was performed as follows. NWT-21 cells were grown in DMEM (high glucose, phate, 1 mM Benzamidin, 0.1 mM PMSF, 0.5 mM Vanadate, 1% NP-40). Protein concentration was determined using Coomasie R Plus Protein Assay 4.5 g/l), 10% FCS, 1% L-glutamine, and 1% Na-pyruvate. 5 ϫ 10 6 cells/ animal were initially injected s.c. into the right flank of five mice. For the Reagent Kit (Pierce; Lausanne, Switzerland). Between 800 g and 1 mg of total cell lysate were incubated with 2 g specific anti-IGF-IR (C-20; Santa in vivo efficacy experiment, tumors of 500 to 800 mm 3 were excised and growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. nonnecrotic areas were cut to fragments of 3 ϫ 3 ϫ 3 mm. growth factor receptor inhibits cell growth, suppresses tumourogenesis, 10 ml/kg dissolved in 25 mM L(ϩ)-tartaric acid, therapy group) or with 25 alters the metastatic potential and prolongs survival in vivo. Cancer Gene mM L(ϩ)-tartaric acid (control group). Antitumor activity was expressed as Ther. 7, 384-395. T/C% (mean increase of tumor volumes of treated animals divided by the mean increase of tumor volumes of control animals multiplied by 100). The experiment Coppola, D., Ferber, A., Miura, M., Sell, C., D'Ambrosio, C., Rubin, R., and was terminated when the mean tumor volume was about 1500 mm 3 . Baserga, R. (1994) . A functional insulin-like growth factor I receptor is reResults are presented as mean Ϯ standard error of the mean (SEM).
quired for the mitogenic and transforming activities of the epidermal growth The differences in tumor volumes and body weights were statistically anafactor receptor. Mol. Cell. Biol. 14, 4588-4595. lyzed using one-way ANOVA with Dunnett test. The level of significance was D'Ambrosio, C., Ferber, A., Resnicoff, N., and Baserga, R. (1996) . A soluble set at p Ͻ 0.05. Statistical analyses were performed using SigmaStat 2.03
Insulin-like growth factor I receptor that induces apoptosis of tumour cells (Jandel Scientific; Zü rich, Switzerland).
in vivo and inhibits tumourogenesis. Cancer Res. 56, 4013-4020.
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